Purified anti-mouse TNF-I+/- [MP6-XT22]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0477348
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $58.10
About this award
The Commonwealth of Virginia, through the University of Virginia, awarded contract A207_PO-0477348 to BioLegend Inc. on September 4, 2026. The contract encompasses the delivery of purified anti-mouse Tumor Necrosis Factor-I+/- (MP6-XT22), a monoclonal antibody reagent, with a total contract value of $58.00. The deliverable consists of a single unit of the specified antibody product, priced at $58.10 per unit, to be delivered to Drew H. Landrowski at the University of Virginia.
BioLegend Inc. serves as the prime contractor for this purchase order, which represents a routine procurement of laboratory reagents by an academic research institution. The University of Virginia's contracting organization facilitated the award to support research activities requiring specialized immunological reagents. No additional contract performance period, annual value, or cumulative value data beyond the stated contract amount has been specified in the available documentation.
Line items
| Item | Total |
|---|---|
| Purified anti-mouse TNF-I+/- [MP6-XT22] | $58.10 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0477348?
Contract A207_PO-0477348 was awarded to BIOLEGEND INC. by University of Virginia on September 4, 2026.
How much is contract A207_PO-0477348 worth?
Its cumulative value is $58.10.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award